Diadema Partners »

Cytomx Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $591k 185k 3.19

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Tang Capital Management
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Balyasny Asset Management
Baker Bros. Advisors
Point72 Asset Management
ADAR1 Capital Management
Kynam Capital Management
Rtw Investments
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics